Stellate Ganglion Neuromodulation for the Treatment of Electrical Storm
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Population Health Research Institute
- Trial code
- NCT07857889
- Record updated
- 8 October 2026
- Original description
Ventricular tachycardia (VT) is a serious heart rhythm problem in which the heart beats very fast and in an abnormal way. These abnormal heart rhythms can be life-threatening. When a person has three or more episodes of VT within a 24-hour period, it is called a "VT storm." VT storm can be difficult to treat because some patients do not respond well to standard medications. Some studies suggest that a procedure called a stellate ganglion block (SGB) may help. An SGB involves injecting a local anesthetic near a group of nerves in the neck that help control signals between the brain and the heart. The procedure can be performed at the bedside using ultrasound guidance.Read full original descriptionShow less
STellate gangliOn neuRoModulatiOn For the Treatment oF Electrical Storm: a Randomized Sham-controlled Trial (STORM-OFF)
Ventricular tachycardia (VT) is a serious heart rhythm problem in which the heart beats very fast and in an abnormal way. These abnormal heart rhythms can be life-threatening. When a person has three or more episodes of VT within a 24-hour period, it is called a "VT storm." VT storm can be difficult to treat because some patients do not respond well to standard medications. Some studies suggest that a procedure called a stellate ganglion block (SGB) may help. An SGB involves injecting a local anesthetic near a group of nerves in the neck that help control signals between the brain and the heart. The procedure can be performed at the bedside using ultrasound guidance.
The purpose of this study is to find out whether SGB can delay or prevent the return of dangerous abnormal heart rhythms in patients with VT storm who are receiving care in an intensive care unit.
If a patient joins the study, they will be randomly assigned (by chance, like flipping a coin) to one of two groups. One group will receive a real stellate ganglion block. The other group will receive a sham procedure, in which a blunt needle will touch the skin but no injection will be given. Patients in the sham group who continue to experience VT may later receive the real procedure.
Participants will be followed until they leave the hospital or for 30 days after joining the study, whichever comes first. The study will take place at five hospitals across Ontario.
Inclusion: Age ≥18 years; ≥3 VT/VF episodes within 24 hours (including appropriate shock or antitachycardia pacing (ATP) terminated events) VT/VF episode definition: ventricular tachyarrhythmia episode ≥30 seconds in duration (VT or VF) requiring intervention regardless of duration, as captured on telemetry, ECG or device intracardiac electrogram; <12 hr since last VT/VF episode.
Exclusion: VT/VF occurring in the setting of acute coronary syndrome prior to revascularization; VT storm due to reversible causes (metabolic, drug mediated, etc.); Standard clinical contraindications to nerve block (e.g., overlying site infection/allergy to the drug, cervical mass or history of neck cancer in the anticipated needle trajectory, others); History of cardiac transplant or cardiac sympathetic denervation (CSD); Platelet count <50,000 /µL; VT storm secondary to underlying ion channelopathies (LQTS, SQTS, Brugada, CPVT, or CRDS); Inability to obtain consent (from patient OR substitute decision maker).